Search the Roll Call archive by keyword, date, Congress, section, or tags.
House Republican leaders released draft legislation Friday consisting of a package of health proposals aimed at reducing health care costs in 2026, setting up a possible floor vote this week.
Under the package, patients wouldn’t see prices that Medicare negotiates directly with drugmakers until 2026, and they would only involve 10 high-cost drugs.
Under the House bill, the Department of Health and Human Services would negotiate prices for insulin and up to 10 drugs without generic competition in 2025, 15 drugs in 2026 and 2027, and 20 drugs afterward